Single Ascending Dose Study of BIIB037 in Participants With Alzheimer's Disease
NCT01397539
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
53
Enrollment
INDUSTRY
Sponsor class
Conditions
Alzheimer's Disease
Interventions
DRUG:
BIIB037
OTHER:
Placebo
Sponsor
Biogen